Results 41 to 50 of about 3,079 (142)

Kaposiform hemangioendothelioma with fatal income: Kasabach–Merritt phenomenon and hypercalcemia

open access: yesClinical Case Reports, 2022
Kaposiform hemangioendothelioma is a rare, borderline tumor that typically occurs during early childhood. Kasabach–Merritt phenomenon is a complication characterized by a consumptive coagulopathy resulting from the localized intravascular coagulation ...
Baklouti Massara   +9 more
doaj   +1 more source

Congenital cutaneous multifocal kaposiform hemangioendothelioma

open access: yes, 1999
Kaposiform hemangioendothelioma is a rare vascular neoplasm in children often associated with Kasabach-Merritt syndrome. The tumor usually presents in retroperitoneal location and is rarely present at birth.
R. Gianotti, C. Gelmetti, E. Alessi
core   +1 more source

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +2 more sources

Treatment of kaposiform hemangioendothelioma [PDF]

open access: yes, 2019
Kaposiform hemangioendothelioma (KHE) is rare neoplasmic disease that is characteristic of newborns (1:7.5 million). Children have an association of KHE with Kasabach — Merritt — Syndrom (KMS).
Hojouj, M., Averin, D.
core   +1 more source

Destructive (Erosive) Tufted Angioma/Kaposiform Hemangioendothelioma of the Eyelid [PDF]

open access: yes, 2020
BACKGROUND: Tufted angioma/kaposiform hemangioendothelioma represents a spectrum of rare benign skin vascular neoplasms that differ in the extent and prognosis.
Abdel-Naser , M. Badawy   +3 more
core   +1 more source

Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma

open access: yesFrontiers in Pediatrics, 2022
Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm associated with the Kasabach–Merritt phenomenon (KMP), which is a consumptive coagulopathy with associated potentially life-threatening thrombocytopenia.
Liang Wang   +9 more
doaj   +1 more source

Epithelioid hemangioendothelioma of the temporal artery presenting as temporal arteritis: Case report and literature review

open access: yesRare Tumors, 2009
Hemangioendotheliomas are classified as epithelioid hemangioendothelioma(EHE), retiform hemangioendothelioma, composite hemanioendothelioma, Kaposiform hemangioendothelioma (with or without Kasabach-Merritt syndrome), and Spindle cell ...
Salem Alowami   +2 more
doaj   +1 more source

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment [PDF]

open access: yes, 2011
Contains fulltext : 98048.pdf (Publisher’s version ) (Open Access)Kaposiform hemangioendothelioma is a rare vascular tumor in children. Especially, in association with the Kasabach-Merritt Phenomenon it can be life threatening.
Beynum, I.M. van   +11 more
core   +1 more source

Endoscopic Suture Ligation and Sclerotherapy for Pharyngolaryngeal Venous Malformation

open access: yesThe Laryngoscope, Volume 136, Issue 8, Page 3477-3486, August 2026.
This study evaluated suture ligation combined with sclerotherapy in 53 patients with pharyngolaryngeal venous malformations. A single procedure achieved complete resolution in 79.25% of cases, with no serious complications or need for prophylactic tracheostomy.
Jiajun Tian   +5 more
wiley   +1 more source

RAS Inhibitor RMC‐7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT RAS mutations occur in patients with several types of vascular anomalies, but effective treatments remain limited. To address this need, we evaluated the RAS (ON) multi‐selective inhibitor RMC‐7977 in human endothelial cells (ECs) expressing the NRASQ61R mutation found in kaposiform lymphangiomatosis (KLA).
Sara Alharbi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy